特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
939857

ワクチンおよび薬物の世界市場:COVID-19の影響を踏まえた、タイプ、最終用途および地域別予測

Global Vaccine and Drugs Market Size study with COVID-19 Impact, by Type (Vaccine, Drugs) by End-Use (Hospitals, Clinics, Others) and Regional Forecasts 2020-2026

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円
ワクチンおよび薬物の世界市場:COVID-19の影響を踏まえた、タイプ、最終用途および地域別予測
出版日: 2020年05月01日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のワクチンおよび医薬品市場を調査し、全体的な市場動向、セグメント別の詳細動向、市場成長への影響要因の分析、競合情勢、主要企業のプロファイルなどを包括的にまとめています。

目次

第1章 エグゼクティブサマリー

第2章 世界のワクチンおよび医薬品市場の定義と範囲

第3章 世界のワクチンおよび医薬品市場力学

  • ワクチンおよび医薬品市場の影響分析

第4章 世界のワクチンおよび医薬品市場:業界分析

  • ポーターの5フォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの提言と結論

第5章 タイプ別世界のワクチンおよび医薬品の市場

  • 市場のスナップショット
  • タイプ別市場の実績 - 潜在力分析
  • タイプ別市場の推定・予測(10億米ドル)
  • ワクチンおよび医薬品の市場、サブセグメント分析
    • ワクチン
    • 医薬品

第6章 エンドユーザー別世界のワクチンおよび医薬品市場

  • 市場のスナップショット
  • エンドユーザー別市場の実績 - 潜在力分析
  • エンドユーザー別市場の推定・予測(10億米ドル)
  • ワクチンおよび医薬品の市場、サブセグメント分析
    • 病院
    • クリニック
    • その他

第7章 世界のワクチンおよび医薬品市場、地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州のスナップショット
    • 英国
    • ドイツ
    • その他欧州
  • アジア太平洋のスナップショット
    • 中国
    • インド
    • 日本
    • その他アジア太平洋地域
  • ラテンアメリカのスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第8章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Pfizer Inc. (米国)
    • Johnson & Johnson Services Inc (米国)
    • GlaxoSmithKline plc. (英国)
    • Sanofi S.A (フランス)
    • Serum Institute of India (インド)
    • Gilead Sciences Inc. (米国)
    • F. Hoffmann-La Roche Ltd (スイス)
    • Merck KGaA (Germany)
    • Janssen Pharmaceuticals, Inc. (ベルギー)

第9章 調査方法

図表

LIST OF TABLES

  • TABLE 1. List of secondary sources, used in the study of global Vaccine and Drugs market
  • TABLE 2. List of primary sources, used in the study of global Vaccine and Drugs market
  • TABLE 3. Global Vaccine and Drugs market, report scope
  • TABLE 4. Years considered for the study
  • TABLE 5. Exchange rates considered
  • TABLE 6. Global Vaccine and Drugs market estimates & forecasts by region 2016-2026 (USD billion)
  • TABLE 7. Global Vaccine and Drugs market estimates & forecasts by type 2016-2026 (USD billion)
  • TABLE 8. Global Vaccine and Drugs market estimates & forecasts by end-user 2016-2026 (USD billion)
  • TABLE 9. Global Vaccine and Drugs market by segment, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 10. Global Vaccine and Drugs market by region, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 11. Global Vaccine and Drugs market by segment, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 12. Global Vaccine and Drugs market by region, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 13. Global Vaccine and Drugs market by segment, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 14. Global Vaccine and Drugs market by region, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 15. Global Vaccine and Drugs market by segment, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 16. Global Vaccine and Drugs market by region, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 17. Global Vaccine and Drugs market by segment, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 18. Global Vaccine and Drugs market by region, estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 19. U.S. Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 20. U.S. Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 21. U.S. Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 22. Canada Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 23. Canada Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 24. Canada Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 25. UK Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 26. UK Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 27. UK Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 28. Germany Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 29. Germany Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 30. Germany Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 31. RoE Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 32. RoE Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 33. RoE Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 34. China Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 35. China Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 36. China Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 37. India Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 38. India Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 39. India Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 40. Japan Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 41. Japan Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 42. Japan Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 43. RoAPAC Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 44. RoAPAC Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 45. RoAPAC Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 46. Brazil Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 47. Brazil Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 48. Brazil Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 49. Mexico Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 50. Mexico Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 51. Mexico Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 52. RoLA Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 53. RoLA Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 54. RoLA Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 55. RoW Vaccine and Drugs market estimates & forecasts, 2016-2026 (USD billion)
  • TABLE 56. RoW Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)
  • TABLE 57. RoW Vaccine and Drugs market estimates & forecasts by segment 2016-2026 (USD billion)

LIST OF FIGURES

  • FIG 1. Global Vaccine and Drugs market, research methodology
  • FIG 2. Global Vaccine and Drugs market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Vaccine and Drugs market, key trends 2019
  • FIG 5. Global Vaccine and Drugs market, growth prospects 2020-2026
  • FIG 6. Global Vaccine and Drugs market, porters 5 force model
  • FIG 7. Global Vaccine and Drugs market, pest analysis
  • FIG 8. Global Vaccine and Drugs market, value chain analysis
  • FIG 9. Global Vaccine and Drugs market by segment, 2016 & 2026 (USD billion)
  • FIG 10. Global Vaccine and Drugs market by segment, 2016 & 2026 (USD billion)
  • FIG 11. Global Vaccine and Drugs market by segment, 2016 & 2026 (USD billion)
  • FIG 12. Global Vaccine and Drugs market by segment, 2016 & 2026 (USD billion)
  • FIG 13. Global Vaccine and Drugs market by segment, 2016 & 2026 (USD billion)
  • FIG 14. Global Vaccine and Drugs market, regional snapshot 2016 & 2026
  • FIG 15. North America Vaccine and Drugs market 2016 & 2026 (USD billion)
  • FIG 16. Europe Vaccine and Drugs market 2016 & 2026 (USD billion)
  • FIG 17. Asia pacific Vaccine and Drugs market 2016 & 2026 (USD billion)
  • FIG 18. Latin America Vaccine and Drugs market 2016 & 2026 (USD billion)
  • FIG 19. Global Vaccine and Drugs market, company market share analysis (2019)
目次

Global Vaccine and Drugs Market is valued approximately at USD XXX billion in 2019 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2020-2026. Vaccines are doses of killed microbes which stimulate the immune systems of the body against that particular microbe, preventing the diseases As the dead microbes of the disease are injected, the body develops resistance towards that particular type of microbe thus preventing the disease when the live microbes attack the human and boosting the immune system and Drugs are the compounds which change the functioning of the consumer when inhaled. Thus, both Vaccines and Drugs are used to prevent and treat diseases. The increase in number of infectious diseases across the globe including Swine Flu, Ebola, Influenza, Tuberculosis, hepatitis and more drive the market for Vaccines and Drugs. These infectious diseases transmit quickly and hence vaccines are required to immunize the population. For Instance: the spread of the COVID-19 virus has steered the vaccine and drug market towards growth. With the disease declared as a pandemic the requirement for its Vaccine and drugs has soared. This is due to the large population being infected by the virus which increases the demand for treatment drugs. As per the World of Meters, as of 6th may 2020, there were around 3.7 million cases of COVID-19 across the globe. The treatment of these huge number of infected people brings a steep incline in the vaccine and drugs market. Due to these treatment efforts, 1.2 million people have been cured. Moreover, to save the rest of the population of the world from the novel Corona Virus, the development of a Vaccine is essential. This has led to increased investments and efforts in the research and development department of the medical sector. Laboratories across the globe are working on developing a vaccine for the virus which has boosted the Vaccine market. As the increasing number of clinical trials propels an increase in the vaccine and drugs market. As of 17th April 2020, the national Medical Products Administration of China approved Two COVID-19 inactivated vaccines for a phase 1 and 2 combined trial. Moreover, in March 2020, two major pharma companies, Pfizer and BioNTech announced a joint venture to co-develop and distribute coronavirus vaccine. Also, in April 2020, Johnson & Johnson announced to produce to 900 million COVID-19 vaccine by the first quarter of 2021.Hence the spread of the pandemic has stimulated share activity in the vaccine and drug market leading to its growth. However, Stringent regulations and Lengthy approval procedure impedes the growth of the market over the forecast period of 2020-2026.

The regional analysis of global Vaccine and Drugs market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the presence of major pharma companies in the region which have the resources to develop the vaccine. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as rising populations and growing number of cases along with early clinical trial approvals would create lucrative growth prospects for the Vaccine and Drugs market across Asia-Pacific region.

Major market player included in this report are:

  • Pfizer Inc. (US)
  • Johnson & Johnson Services Inc (US)
  • GlaxoSmithKline plc. (UK)
  • Sanofi S.A (France)
  • Serum Institute of India (India)
  • Gilead Sciences Inc. (US)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Merck KGaA (Germany)
  • Janssen Pharmaceuticals, Inc. (Belgium)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Vaccine
  • Drugs

By End-use:

  • Hospitals
  • Clinicals
  • Others

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2016, 2017, 2018
  • Base year - 20198
  • Forecast period - 2020 to 2026

Target Audience of the Global Vaccine and Drugs Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
    • 1.2.1. Vaccine and Drugs Market, by Region, 2018-2026 (USD Billion)
    • 1.2.2. Vaccine and Drugs Market, by Type, 2018-2026 (USD Billion)
    • 1.2.3. Vaccine and Drugs Market, by End-User, 2018-2026 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Vaccine and Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Vaccine and Drugs Market Dynamics

  • 3.1. Vaccine and Drugs Market Impact Analysis (2018-2026)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Vaccine and Drugs Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Vaccine and Drugs Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Vaccine and Drugs Market by Type, Performance - Potential Analysis
  • 5.3. Global Vaccine and Drugs Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
  • 5.4. Vaccine and Drugs Market, Sub Segment Analysis
    • 5.4.1. Vaccine
    • 5.4.2. Drugs

Chapter 6. Global Vaccine and Drugs Market, by End-User

  • 6.1. Market Snapshot
  • 6.2. Global Vaccine and Drugs Market by End-User, Performance - Potential Analysis
  • 6.3. Global Vaccine and Drugs Market Estimates & Forecasts by End-User 2016-2026 (USD Billion)
  • 6.4. Vaccine and Drugs Market, Sub Segment Analysis
    • 6.4.1. Hospitals
    • 6.4.2. Clinics
    • 6.4.3. Others

Chapter 7. Global Vaccine and Drugs Market, Regional Analysis

  • 7.1. Vaccine and Drugs Market, Regional Market Snapshot
  • 7.2. North America Vaccine and Drugs Market
    • 7.2.1. U.S. Vaccine and Drugs Market
      • 7.2.1.1. Type breakdown estimates & forecasts, 2016-2026
      • 7.2.1.2. End-User breakdown estimates & forecasts, 2016-2026
    • 7.2.2. Canada Vaccine and Drugs Market
  • 7.3. Europe Vaccine and Drugs Market Snapshot
    • 7.3.1. U.K. Vaccine and Drugs Market
    • 7.3.2. Germany Vaccine and Drugs Market
    • 7.3.3. Rest of Europe Vaccine and Drugs Market
  • 7.4. Asia-Pacific Vaccine and Drugs Market Snapshot
    • 7.4.1. China Vaccine and Drugs Market
    • 7.4.2. India Vaccine and Drugs Market
    • 7.4.3. Japan Vaccine and Drugs Market
    • 7.4.4. Rest of Asia Pacific Vaccine and Drugs Market
  • 7.5. Latin America Vaccine and Drugs Market Snapshot
    • 7.5.1. Brazil Vaccine and Drugs Market
    • 7.5.2. Mexico Vaccine and Drugs Market
  • 7.6. Rest of The World Vaccine and Drugs Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Pfizer Inc. (US)
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Johnson & Johnson Services Inc (US)
    • 8.2.3. GlaxoSmithKline plc. (UK)
    • 8.2.4. Sanofi S.A (France)
    • 8.2.5. Serum Institute of India (India)
    • 8.2.6. Gilead Sciences Inc. (US)
    • 8.2.7. F. Hoffmann-La Roche Ltd (Switzerland)
    • 8.2.8. Merck KGaA (Germany)
    • 8.2.9. Janssen Pharmaceuticals, Inc. (Belgium)

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.